April 2024 - Page 3 of 8 - NetworkNewsWire

MondayApr 22, 2024 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks GLP-1 Study Milestone with Ethics Review Board Approval

Lexaria, a global innovator in drug delivery platforms, has received approval for its GLP-1 human pilot study #2 by an independent third-party ethics review board GLP-1 drugs are utilized in the treatment of type 2 diabetes and obesity, a huge market, and are typically administered by painful and expensive injection, offering a major opportunity for Lexaria’s oral delivery platform This approval sets the company up for dosing within 30 days or less, with tentative study completion dates for this summer The study will comprise two study arms, the second study arm will investigate whether Lexaria’s patented DehydraTECH(TM)-enhanced semaglutide can effectively…

MondayApr 22, 2024 10:30 am

Clene Inc. (NASDAQ: CLNN) Continues Development of Lead Drug Candidate CNM Au8(R) for Neurodegenerative Diseases including Parkinson’s Disease

CNM-Au8 is an oral suspension with demonstrated activity in restoring neuronal health and function by increasing energy production and utilization Treatment with CNM-Au8 investigated in clinical trials adjunctive to standard-of-care exhibits no known drug interactions, and aims to enhance function and survival Nearly 90,000 people are diagnosed with Parkinson's disease every year with no approved drug to slow or halt disease progression currently available The Parkinson's disease treatment market was valued at $4.61 billion in 2022 and is expected to reach $11.98 billion by 2030 In recognition of April as Parkinson’s Disease Awareness Month, IBN is highlighting Clene (NASDAQ: CLNN),…

MondayApr 22, 2024 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Announces Dates for Qubits 2024 Quantum Computing Conference in Boston

D-Wave’s Qubits 2024 annual quantum computing conference will take place in Boston, Massachusetts, on June 17 and 18, 2024 The two-day event will explore the transformative potential of D-Wave's quantum technologies as they tackle complex computational challenges across supply chain logistics, manufacturing, government, and the life sciences sectors Participants will learn about D-Wave customers’ powerful quantum-hybrid applications, the company’s latest quantum technology innovations, and updates on the company’s latest groundbreaking scientific research D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software, and services and the world's first commercial supplier of quantum computers, recently announced that its Qubits 2024…

MondayApr 22, 2024 9:00 am

SUIC Worldwide Holdings Ltd. (SUIC) Eyes Significant Share of Growing Global Supply Chain Financial Market with Proprietary All-in-One B2B2C System

SUIC and Beneway USA have rolled out a proprietary B2B2C system, a superior all-in-one payment and total financing solution that combines the capabilities and benefits of SUIC’s B2B e-commerce model with those of its proprietary B2C platform The B2B model streamlines business processes and enables businesses to develop and implement substantial growth opportunities as well as optimize costs The all-in-one B2C platform integrates payment systems, electronic invoice devices, mobile cash registers, POS system devices, enterprise resource planning, big data, AI, value-added cloud services, and other services SUIC hopes the B2B2C system, combined with cutting-edge technologies and solutions the company continues…

FridayApr 19, 2024 11:15 am

Fast-Tracking a Capital Raise in the Public Markets

The SPAC Conference 2024 Hosted by DealFlow Events Successful people know when facing a business challenge their best weapon is information. Anyone involved in any way with special purpose acquisition companies cannot afford to miss The SPAC Conference 2024 coming up fast. This best-in-class event set for June 11-12 delivers the vital information and insight you need to overcome challenges and take full advantage of the capital-raise benefits available through the SPAC market. DealFlow’s annual SPAC Conference will be held at the luxurious Westchester Country Club in Rye, New York, a superb venue for networking and learning. This annual event…

FridayApr 19, 2024 10:30 am

New Rare Earths Resource Estimate Showcases World-Class Project

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) will already be familiar to many readers via a previous full-length feature article [https://nnw.fm/sZDwE]. In that piece, we labeled the previous spectacular drill results from Appia’s PCH Ionic Adsorption Clays Project “a game-changer”. Since that time, Appia has released a maiden mineral resource estimate (“MRE”) for the PCH Project based upon that drilling data. The impressive numbers for this REE deposit fully justify our original assessment. Appia Announces Maiden Rare Earth Mineral Resource Estimate of 6.6 Million Tonnes Indicated Grading 2,513 ppm TREO and 46.2 Million Tonnes Inferred grading 2,888 ppm…

FridayApr 19, 2024 9:45 am

TimeFree Solutions Is ‘One to Watch’

TimeFree Solutions is a company dedicated to providing comprehensive solutions for optimizing business processes and maximizing efficiency The company provides marketing services, primarily lead generation, to companies ranging from startups to established firms In April 2024, TimeFree Solutions acquired established lead generation firm G2LeadsToSales.com The lead generation solutions market is forecast to be worth $18.27 billion by 2032, expanding at a CAGR of 17.5% during the preceding 10 years TimeFree Solutions is a company dedicated to providing comprehensive offerings for optimizing business processes and maximizing efficiency. The company specializes in understanding various aspects of businesses, including target audience, market dynamics,…

FridayApr 19, 2024 9:00 am

Securing a Domestic Supply Chain: Why Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Matters for North America

North America is deeply dependent on foreign nickel, which is a position of weakness for meeting EV and carbon goals Canada has the potential to once again be a dominant player in nickel production thanks to companies like Fathom Nickel The company holds a dominant land position in the prolific Trans Hudson Corridor, controlling over 113,000 hectares of highly prospective property, inclusive of a past producing nickel mine The rise and fall of Canada's nickel production in recent years highlights a critical issue for North America – dependence on foreign sources of this essential metal. Despite a resurgence in 2023,…

ThursdayApr 18, 2024 12:45 pm

Essentials to Know When Marketing a Reg A or Reg CF Capital Raise

Regulation A (Reg A) and Regulation Crowdfunding (Reg CF) offer alternatives to traditional financing such as bank loans, venture capital, or initial public offerings (“IPOs”). While traditional financing typically involves stringent eligibility criteria, a lengthy approval process and substantial fees, Reg A and Reg CF provide greater flexibility for raising capital. Marketing a Reg A or Reg CF capital raise involves understanding the target audience, crafting compelling messages, and utilizing multiple channels such as social media, email campaigns, and press releases Compliance with SEC regulations is crucial for issuers, including adherence to advertising restrictions and providing accurate and comprehensive information…

ThursdayApr 18, 2024 12:00 pm

DGE 3rd Diversity in Clinical Trials Invites Pharmaceutical Professionals for Enlightening Discussions

DGE invites life science professionals to attend the 3rd Diversity In Clinical Trials Conference being held on May 15-16, 2024 at the Inn at Penn Philadelphia. The conference offers an valuable forum for meaningful interactions to understand the intricacies of and benefits of pursuing diverse enrollment in clinical studies. The event is hosted by Dynamic Global Events (“DGE”), a global leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the pharma, biotech, medical devices, and all healthcare industries. New insights and successful strategies are pivotal for better clinical trial results. Pharma…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: April 2024